Angela Hwang

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance
0.9
Performance over holding periods
0.9
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Group President, Pfizer Biopharmaceuticals Group Pfizer Inc Jan. 1, 2019 -
Group President - Pfizer Essential Health Pfizer Inc Jan. 1, 2018 - Dec. 1, 2018
Angela Hwang's trades of Pfizer Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Pfizer Inc (PFE)
Transaction date
Sale
Price
309.97
Quantity 63,675 -33.1%
Value US$2,299,343
US Pfizer Inc (PFE)
Transaction date
Sale
Price
57.51
Quantity 4,271 -9.7%
Value US$4,375,733
US Pfizer Inc (PFE)
Transaction date
Sale
Price
73.20
Quantity 61,723 -45.9%
Value US$1,017,339
US Pfizer Inc (PFE)
Transaction date
Sale
Price
49.61
Quantity 800 -3.1%
Value US$39,688
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-15 2021-11-12
US Pfizer Inc (PFE)
S Sale
63,675 -33.1%
309.97
US$2,299,343 		63,675 -33.1% 309.97 US$2,299,343
2021-11-15 2021-11-12
US Pfizer Inc (PFE)
S Sale
4,271 -9.7%
57.51
US$4,375,733 		4,271 -9.7% 57.51 US$4,375,733
2021-11-15 2021-11-12
US Pfizer Inc (PFE)
S Sale
61,723 -45.9%
73.20
US$1,017,339 		61,723 -45.9% 73.20 US$1,017,339
2021-11-15 2021-11-12
US Pfizer Inc (PFE)
S Sale
800 -3.1%
49.61
US$39,688 		800 -3.1% 49.61 US$39,688